Literature DB >> 15220683

Predominant symptom behavior in patients with persistent dyspepsia during treatment.

Robert J F Laheij1, Ruud W De Koning, Alfonds M Horrevorts, Rob J Rongen, Leo G M Rossum, Ellen M Witteman, Jan T H Hermsen, Jan B M J Jansen.   

Abstract

BACKGROUND: Grouping of patients based on a predominant dyspeptic symptom is frequently employed in management strategies for dyspepsia. Such subdivision, however, suggests that dyspeptic symptom patterns are constant over time.
OBJECTIVE: To investigate the behavior of symptoms over time and to study the effects of diagnostic procedures and treatment on the pattern and severity of dyspeptic symptoms.
METHODS: Patients with persistent dyspeptic symptoms completed a validated questionnaire at regular time intervals as part of a clinical trial in primary care. Based on predominant symptoms, patients were classified into ulcer-like dyspepsia, reflux-like dyspepsia, dysmotility-like dyspepsia, and unspecific dyspepsia according to the Rome II criteria.
RESULTS: Questionnaires were returned at baseline, 1, 3, and 6 months by 185, 172, 169, and 170 patients, respectively. At baseline, 35% of patients reported predominantly reflux-like dyspepsia, 34% had ulcer-like dyspepsia, 16% had dysmotility-like dyspepsia, and in 15% symptoms were not specific. During the 6-month follow-up period, only 35% of patients kept the same predominant symptom. Symptom (in)stability was not dependent on diagnostic procedures or on therapy with proton pump inhibitors, H2-receptor antagonists, prokinetics, or antacids.
CONCLUSION: In the majority of dyspeptic patients, symptoms change continuously as time goes on. Symptom instability is not influenced by diagnostic procedures or therapy. Thus, there is little sense in symptom-based management of dyspepsia in primary care.

Entities:  

Mesh:

Year:  2004        PMID: 15220683     DOI: 10.1097/01.mcg.0000123164.86324.24

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  7 in total

1.  Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.

Authors:  Andrew K Roorda; Samuel N Marcus; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-04-22       Impact factor: 3.199

2.  Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.

Authors:  Masahiro Sakaguchi; Miyuki Takao; Yasuo Ohyama; Hiroshi Oka; Hiroshi Yamashita; Takumi Fukuchi; Kiyoshi Ashida; Masahiro Murotani; Masuyo Murotani; Kazuo Majima; Hiroshi Morikawa; Takashi Hashimoto; Keisuke Kiyota; Hirohiko Esaki; Kanji Amemoto; Gouhei Isowa; Fumiyuki Takao
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

3.  Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?

Authors:  Yao-Chun Hsu; Jyh-Ming Liou; Tzeng-Huey Yang; Wei-Lun Hsu; Hwai-Jeng Lin; Huei-Tang Wu; Jaw-Town Lin; Hsiu-Po Wang; Ming-Shiang Wu
Journal:  J Gastroenterol       Date:  2010-10-19       Impact factor: 7.527

4.  Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis.

Authors:  Hiroaki Kusunoki; Masayasu Kusaka; Soichiro Kido; Ryo Yamauchi; Yoshinori Fujimura; Yasuyuki Watanabe; Michio Kobori; Hiroto Miwa; Toshihiko Tomita; Yongmin Kin; Kazutoshi Hori; Nobuo Tano; Kenji Sugimoto; Yoshihiro Nakamura; Kazuma Fujimoto; Noriko Oza; Aki Matsunobu; Naofumi Ono; Seisuke Fuyuno; Yoshikazu Kinoshita; Kyoichi Adachi; Mika Yuki; Tomoo Fujisawa; Ken Haruma
Journal:  J Gastroenterol       Date:  2009-03-13       Impact factor: 7.527

Review 5.  Functional dyspepsia--symptoms, definitions and validity of the Rome III criteria.

Authors:  Jan Tack; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-12       Impact factor: 46.802

6.  Functional dyspepsia: subtypes, risk factors, and overlap with irritable bowel syndrome in a population of african patients.

Authors:  Sylvester Chuks Nwokediuko; Uchenna Ijoma; Olive Obienu
Journal:  Gastroenterol Res Pract       Date:  2012-11-19       Impact factor: 2.260

Review 7.  Functional dyspepsia: past, present, and future.

Authors:  Brecht Geeraerts; Jan Tack
Journal:  J Gastroenterol       Date:  2008-05-06       Impact factor: 6.772

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.